Skip to main content

Enzo Biochem Inc

ENZBDelisted Apr 7, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000316253

Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in Enzo Biochem Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−2 vs. Q1 2024
Shares held
12.4M
−1.44M (−10.4%) vs. Q1 2024
Total value
$13.5M
−$4.06M (−23.1%) vs. Q1 2024
New holders
4
8 more added
Sold out
6
9 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 39 institutions
Q1 2021: 82 institutionsQ2 2021: 72 institutionsQ3 2021: 65 institutionsQ4 2021: 59 institutionsQ1 2022: 51 institutionsQ2 2022: 54 institutionsQ3 2022: 49 institutionsQ4 2022: 52 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 39 institutionsQ4 2023: 46 institutionsQ1 2024: 41 institutionsQ2 2024: 39 institutionsQ3 2024: 43 institutionsQ4 2024: 44 institutionsQ1 2025: 41 institutionsQ2 2025: 7 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $13.5M
Q1 2021: $94.6MQ2 2021: $76.6MQ3 2021: $82.9MQ4 2021: $69.0MQ1 2022: $62.0MQ2 2022: $43.8MQ3 2022: $45.6MQ4 2022: $26.8MQ1 2023: $48.1MQ2 2023: $34.7MQ3 2023: $23.1MQ4 2023: $22.7MQ1 2024: $17.6MQ2 2024: $13.5MQ3 2024: $14.2MQ4 2024: $9.71MQ1 2025: $4.96MQ2 2025: $2.00MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ENZB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20257$2.00M
Q1 202541$4.96M
Q4 202444$9.71M
Q3 202443$14.2M
Q2 202439$13.5M
Q1 202441$17.6M
Q4 202346$22.7M
Q3 202339$23.1M
Q2 202347$34.7M
Q1 202352$48.1M
Q4 202252$26.8M
Q3 202249$45.6M
Q2 202254$43.8M
Q1 202251$62.0M
Q4 202159$69.0M
Q3 202165$82.9M
Q2 202172$76.6M
Q1 202182$94.6M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q1 2024.

Institutions holding ENZB in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Harbert Fund Advisors, Inc.5,175,913$5.64M4.53%00.0%Unchanged
Renaissance Technologies LLC2,499,546$2.72M0.00%+64,417+2.6%Added
Vanguard Group Inc1,876,622$2.05M0.00%00.0%Unchanged
BlackRock Inc.955,023$1.04M0.00%+1,032+0.1%Added
Geode Capital Management, LLC356,904$389.1K0.00%+19,048+5.6%Added
Dimensional Fund Advisors LP340,333$371.0K0.00%−315,462−48.1%Reduced
RBF Capital, LLC250,359$272.9K0.02%00.0%Unchanged
State Street Corp154,139$168.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC132,100$144.0K0.00%−95,000−41.8%Reduced
Wittenberg Investment Management, Inc.117,137$127.7K0.04%+49,134+72.3%Added
Nierenberg Investment Management Company, Inc.88,555$96.5K0.06%+77,000+666.4%Added
Morgan Stanley71,755$78.2K0.00%00.0%Unchanged
Northern Trust Corp67,204$73.3K0.00%−54−0.1%Reduced
Lazard Asset Management LLC50,453$54.0K0.00%+50,453New
Price T Rowe Associates Inc44,800$49.0K0.00%00.0%Unchanged
XTX Topco Ltd28,262$30.8K0.00%+13,735+94.5%Added
Kempner Capital Management Inc.25,475$28.0K0.01%00.0%Unchanged
Assenagon Asset Management S.A.19,773$21.6K0.00%00.0%Unchanged
Millennium Management LLC19,363$21.1K0.00%+19,363New
Raymond James Trust N.A.17,016$18.5K0.00%00.0%Unchanged
Shulman DeMeo Asset Management LLC15,487$16.9K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The14,955$16.3K0.00%+14,955New
Charles Schwab Investment Management Inc13,471$14.7K0.00%00.0%Unchanged
TLS Advisors LLC13,616$14.0K0.04%+13,616New
Snowden Capital Advisors LLC12,045$13.1K0.00%−8,400−41.1%Reduced
Tower Research Capital LLC (TRC)4,263$4.65K0.00%−7,850−64.8%Reduced
Covestor Ltd3,967$4.00K0.00%00.0%Unchanged
BFSG, LLC2,813$3.07K0.00%00.0%Unchanged
Bank of America Corp2,214$2.41K0.00%−174−7.3%Reduced
JPMorgan Chase & Co1,833$2.00K0.00%00.0%Unchanged
Royal Bank of Canada1,081$1.00K0.00%00.0%Unchanged
Simplex Trading, LLC1,601$1.00K0.00%+720+81.7%Added
UBS Group AG723$7880.00%+445+160.1%Added
Wells Fargo & Company578$6300.00%−304−34.5%Reduced
FMR LLC429$4680.00%−1,556−78.4%Reduced
Advisor Group Holdings, Inc.120$1310.00%−1,003−89.3%Reduced
Clear Point Advisors Inc.120$1310.00%00.0%Unchanged
Sound Income Strategies, LLC10$110.00%00.0%Unchanged
Benjamin Edwards Inc300$00.00%00.0%Unchanged
Tang Capital Management LLC0$00.00%−1,260,013−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−24,270−100.0%Sold out
Paradigm Financial Partners, LLC0$00.00%−19,500−100.0%Sold out
PFG Investments, LLC0$00.00%−18,662−100.0%Sold out
Sage Mountain Advisors LLC0$00.00%−14,195−100.0%Sold out
GWM Advisors LLC0$00.00%−10−100.0%Sold out